Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust (REIT) that pioneered the life science real estate niche. The company's mission is to create and grow inspiring campuses and ecosystems that ignite collaboration and advance life-changing innovation, empowering leading life science and technology companies to enhance human health and longevity. Its headquarters are located in Pasadena, California, U.S..
Alexandria Real Estate Equities specializes in the ownership, operation, development, and redevelopment of Class A/A+ office buildings and laboratories. These properties are strategically clustered in collaborative "Megacampus™ ecosystems" across key innovation hubs, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. The company primarily serves tenants in the life science, agtech, and technology industries, encompassing multinational pharmaceutical companies, biotechnology firms, academic and medical research institutions, and government agencies. Additionally, Alexandria operates Alexandria Venture Investments, a venture capital platform that provides strategic capital to transformative life science companies.
As of March 31, 2026, Alexandria Real Estate Equities maintained a total market capitalization of $20.44 billion. The company reported 1Q26 net income per share of $2.10 and FFO per share of $1.73, and declared a quarterly cash dividend of $0.72 per common share for the same period. Joel S. Marcus serves as the Executive Chairman and Founder, while Peter M. Moglia is the Chief Executive Officer and Chief Investment Officer. The company has been recognized as one of the "Most Trustworthy Companies in America" by Newsweek for the fourth consecutive year and one of the "Most Charitable Companies in America" in March 2026. Despite a challenging operating environment, the company continues to focus on its strategic objectives, though it has adjusted its year-end 2026 occupancy guidance to 87%.
Latest updates
